TFF Pharmaceuticals Inc (TFFP)
2.098
+0.05
(+2.33%)
USD |
NASDAQ |
May 31, 16:00
2.05
-0.05
(-2.27%)
After-Hours: 20:00
TFF Pharmaceuticals Cash from Financing (Quarterly): 0.9011M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.9011M |
| December 31, 2023 | 0.0006M |
| September 30, 2023 | 5.09M |
| June 30, 2023 | -0.0592M |
| March 31, 2023 | -0.0179M |
| December 31, 2022 | 11.34M |
| September 30, 2022 | 0.4307M |
| June 30, 2022 | -0.016M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2021 | 0.026M |
| March 31, 2021 | 28.86M |
| December 31, 2020 | 0.7144M |
| September 30, 2020 | 24.28M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 21.85M |
| September 30, 2019 | -0.0102M |
| June 30, 2019 | 7.208M |
| March 31, 2019 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.0592M
Minimum
Jun 2023
28.86M
Maximum
Mar 2021
5.030M
Average
0.0133M
Median
Cash from Financing (Quarterly) Benchmarks
| Lifecore Biomedical Inc | 40.93M |
| Jaguar Health Inc | 12.27M |
| Genprex Inc | 6.793M |
| Aquestive Therapeutics Inc | 81.74M |
| NovaBay Pharmaceuticals Inc | -0.597M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.144M |
| Free Cash Flow | -14.82M |
| Free Cash Flow Per Share (Quarterly) | -1.317 |
| Free Cash Flow to Equity (Quarterly) | -3.144M |
| Free Cash Flow Yield | -348.6% |